Klebsiella vaccine

Drug Profile

Klebsiella vaccine

Alternative Names: Klebgen Berna

Latest Information Update: 09 Jul 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Berna Biotech; Punjab University-Chandigarh
  • Developer Walter Reed Army Institute of Research
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Klebsiella infections

Most Recent Events

  • 09 Jul 2002 Discontinued - Phase-I for Klebsiella infections in USA (IM)
  • 08 Oct 1999 No-Development-Reported for Klebsiella infections in India (Unknown route)
  • 08 Oct 1999 No-Development-Reported for Klebsiella infections in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top